Skip to main content

Table 9 Base case cost-effectiveness results (intervention: olanzapine ODT)

From: An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco

Strategy

Total cost (MAD)

Total QALY

ICER (cost/QALY)

Olanzapine ODT

MAD 3034

0.7916

–

Olanzapine

MAD 3106

0.7733

− MAD 3921

Risperidone ODT

MAD 3710

0.7850

− MAD 102,298

Risperidone

MAD 3811

0.7666

− MAD 31,088

Aripiprazole ODT

MAD 3675

0.7822

− MAD 68,032

Aripiprazole

MAD 3728

0.7633

− MAD 24,516

  1. ODT orally disintegrating tablet (formulation), QALY quality-adjusted life years [willingness to pay (WTP) = MAD 250,832.40]
Back to article page

Annals of General Psychiatry

ISSN: 1744-859X